Ethical Dilemmas of Using Artificial Intelligence in Medicine.

IF 2.9 4区 医学 Q2 PHARMACOLOGY & PHARMACY American journal of therapeutics Pub Date : 2024-04-25 DOI:10.1097/MJT.0000000000001693
Vasile Astărăstoae, Liliana M. Rogozea, F. Leaşu, Beatrice Gabriela Ioan
{"title":"Ethical Dilemmas of Using Artificial Intelligence in Medicine.","authors":"Vasile Astărăstoae, Liliana M. Rogozea, F. Leaşu, Beatrice Gabriela Ioan","doi":"10.1097/MJT.0000000000001693","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nArtificial intelligence (AI) is considered the fourth industrial revolution that will change the evolution of humanity technically and relationally. Although the term has been around since 1956, it has only recently become apparent that AI can revolutionize technologies and has many applications in the medical field.\n\n\nAREAS OF UNCERTAINTY\nThe ethical dilemmas posed by the use of AI in medicine revolve around issues related to informed consent, respect for confidentiality, protection of personal data, and last but not least the accuracy of the information it uses.\n\n\nDATA SOURCES\nA literature search was conducted through PubMed, MEDLINE, Plus, Scopus, and Web of Science (2015-2022) using combinations of keywords, including: AI, future in medicine, and machine learning plus ethical dilemma.\n\n\nETHICS AND THERAPEUTIC ADVANCES\nThe ethical analysis of the issues raised by AI used in medicine must mainly address nonmaleficence and beneficence, both in correlation with patient safety risks, ability versus inability to detect correct information from inadequate or even incorrect information. The development of AI tools that can support medical practice can increase people's access to medical information, to obtain a second opinion, for example, but it is also a source of concern among health care professionals and especially bioethicists about how confidentiality is maintained and how to maintain cybersecurity. Another major risk may be related to the dehumanization of the medical act, given that, at least for now, empathy and compassion are accessible only to human beings.\n\n\nCONCLUSIONS\nAI has not yet managed to overcome certain limits, lacking moral subjectivity, empathy, the level of critical thinking is still insufficient, but no matter who will practice preventive or curative medicine in the next period, they will not be able to ignore AI, which under human control can be an important tool in medical practice.","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MJT.0000000000001693","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Artificial intelligence (AI) is considered the fourth industrial revolution that will change the evolution of humanity technically and relationally. Although the term has been around since 1956, it has only recently become apparent that AI can revolutionize technologies and has many applications in the medical field. AREAS OF UNCERTAINTY The ethical dilemmas posed by the use of AI in medicine revolve around issues related to informed consent, respect for confidentiality, protection of personal data, and last but not least the accuracy of the information it uses. DATA SOURCES A literature search was conducted through PubMed, MEDLINE, Plus, Scopus, and Web of Science (2015-2022) using combinations of keywords, including: AI, future in medicine, and machine learning plus ethical dilemma. ETHICS AND THERAPEUTIC ADVANCES The ethical analysis of the issues raised by AI used in medicine must mainly address nonmaleficence and beneficence, both in correlation with patient safety risks, ability versus inability to detect correct information from inadequate or even incorrect information. The development of AI tools that can support medical practice can increase people's access to medical information, to obtain a second opinion, for example, but it is also a source of concern among health care professionals and especially bioethicists about how confidentiality is maintained and how to maintain cybersecurity. Another major risk may be related to the dehumanization of the medical act, given that, at least for now, empathy and compassion are accessible only to human beings. CONCLUSIONS AI has not yet managed to overcome certain limits, lacking moral subjectivity, empathy, the level of critical thinking is still insufficient, but no matter who will practice preventive or curative medicine in the next period, they will not be able to ignore AI, which under human control can be an important tool in medical practice.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在医学中使用人工智能的伦理困境。
背景人工智能(AI)被认为是第四次工业革命,将在技术上和关系上改变人类的进化。虽然这个词从 1956 年就出现了,但直到最近,人们才发现人工智能可以彻底改变技术,并在医学领域有许多应用。不确定领域人工智能在医学中的应用所带来的伦理困境围绕着与知情同意、尊重保密性、保护个人数据有关的问题,最后但并非最不重要的是它所使用信息的准确性:人工智能、医学的未来、机器学习加伦理困境。伦理与治疗学发展对人工智能用于医学所引发问题的伦理分析必须主要解决非 "善 "与 "善 "的问题,两者都与患者安全风险、从不足甚至不正确的信息中检测出正确信息的能力与能力相关。开发能够支持医疗实践的人工智能工具可以增加人们获取医疗信息的途径,例如获得第二意见,但这也引起了医疗专业人士,特别是生命伦理学者对如何保密以及如何维护网络安全的担忧。另一个主要风险可能与医疗行为的非人性化有关,因为至少目前,只有人类才能获得同理心和同情心。人工智能尚未克服某些限制,缺乏道德主观性、同理心、批判性思维水平仍然不足,但无论谁将在下一阶段从事预防或治疗医学,他们都无法忽视人工智能,因为在人类的控制下,人工智能可以成为医疗实践中的重要工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American journal of therapeutics
American journal of therapeutics PHARMACOLOGY & PHARMACY-
CiteScore
5.50
自引率
9.50%
发文量
142
审稿时长
6-12 weeks
期刊介绍: American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.
期刊最新文献
A Study on Periorbital Edema Following Postcollagen Injection. New Insights Into Pharmacology of GABAA Receptor Alpha Subunits-Selective Modulators. Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials. Eosinophil-Related Disorders With Myelitis as the Predominant Clinical Manifestation: A Case Report. Rivaroxaban-Associated Neutropenia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1